"Self" and "nonself" manipulation of interferon defense during persistent infection: Bovine viral diarrhea virus resists alpha/beta interferon without blocking antiviral activity against unrelated viruses replicating in its host cells

Journal of Virology

Volumn 80, Issue 14, 2006, Pages 6926-6935

  Schweizer, Matthias ^a   Mätzener, Philippe ^a   Pfaffen, Gabriela ^a   Stalder, Hanspeter ^a   Peterhans, Ernst ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DOUBLE STRANDED RNA; MYXOVIRUS RESISTANCE PROTEIN;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; BIOTYPE; BOVINE DIARRHEA VIRUS; CATTLE DISEASE; CELL CULTURE; CYTOPATHOGENIC EFFECT; HOST CELL; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; INTRAUTERINE INFECTION; NONHUMAN; PERSISTENT INFECTION; PESTIVIRUS; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALS; APOPTOSIS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CATTLE DISEASES; CELLS, CULTURED; CYTOPATHOGENIC EFFECT, VIRAL; DIARRHEA VIRUSES, BOVINE VIRAL; FEMALE; FETAL DISEASES; GTP-BINDING PROTEINS; IMMUNE TOLERANCE; INTERFERON-ALPHA; INTERFERON-BETA; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, DOUBLE-STRANDED; RNA, VIRAL; SPECIES SPECIFICITY; VIRUS REPLICATION;

ANIMALIA; BORDER DISEASE VIRUS; BOVINE VIRAL DIARRHEA VIRUS 1; CLASSICAL SWINE FEVER VIRUS; FLAVIVIRIDAE; OVIS ARIES; PESTIVIRUS;

EID: 33745772364     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02443-05     Document Type: Article

References (81)

1. Adler, B., H. Adler, T. W. Jungi, and E. Peterhans. 1995. Interferon-alpha primes macrophages for lipopolysaccharide-induced apoptosis. Biochem. Biophys. Res. Commun. 215:921-927.
2. Adler, B., H. Adler, H. Pfister, T. W. Jungi, and E. Peterhans. 1997. Macrophages infected with cytopathic bovine viral diarrhea virus release a factor(s) capable of priming uninfected macrophages for activation-induced apoptosis. J. Virol. 71:3255-3258.
3. Adler, H., B. Frech, P. Meier, T. W. Jungi, and E. Peterhans. 1994. Non-cytopathic strains of bovine viral diarrhea virus prime bovine bone marrow-derived macrophages for enhanced generation of nitric oxide. Biochem. Biophys. Res. Commun. 202:1562-1568.
4. Aebi, M., J. Fäh, N. Hurt, C. E. Samuel, D. Thomis, L. Bazzigher, J. Pavlovic, O. Haller, and P. Staeheli. 1989. cDNA structures and regulation of two interferon-induced human Mx proteins. Mol. Cell. Biol. 9:5062-5072.
5. Alcamí, A., and U. H. Koszinowski. 2000. Viral mechanisms of immune evasion. Immunol. Today 21:447-455.
6. Anonymous. 1999. Hepatitis C-global prevalence. Wkly. Epidemiol. Rec. 74:421-428.
7. Asano, A., J. H. Ko, T. Morozumi, N. Hamashima, and T. Watanabe. 2002. Polymorphisms and the antiviral property of porcine Mx1 protein. J. Vet. Med. Sci. 64:1085-1089.
8. Atreya, P. L., and S. Kulkarni. 1999. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA. Virology 261:227-241.
9. Baigent, S. J., G. Zhang, M. D. Fray, H. Flick-Smith, S. Goodbourn, and J. W. McCauley. 2002. Inhibition of beta interferon transcription by non-cytopathogenic bovine viral diarrhea virus is through an interferon regulatory factor 3-dependent mechanism. J. Virol. 76:8979-8988.
10. Baise, E., G. Pire, M. Leroy, J. Gerardin, N. Goris, K. De Clercq, P. Kerkhofs, and D. Desmecht. 2004. Conditional expression of type I interferon-induced bovine Mx1 GTPase in a stable transgenic Vero cell line interferes with replication of vesicular stomatitis virus. J. Interferon Cytokine Res. 24:513-521.
11. Bielefeldt Ohmann, H. 1995. The pathologies of bovine viral diarrhea virus infection. A window on the pathogenesis. Vet. Clin. N. Am. Food Anim. Pract. 11:447-476.
12. 11 and γ and of tumour necrosis factor on persistent infection with bovine viral diarrhoea virus in vitro. J. Gen. Virol. 69:1399-1403.
13. Bolin, S. R., and J. F. Ridpath. 1996. The clinical significance of genetic variation among bovine viral diarrhea viruses. Vet. Med. 91:958-961.
14. Bonjardim, C. A. 2005. Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses-and viruses counteract IFN action. Microbes Infect. 7:569-578.
15. Borrow, P., and G. M. Shaw. 1998. Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo? Immunol. Rev. 164:37-51.
16. Bossert, B., S. Marozin, and K. K. Conzelmann. 2003. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J. Virol. 77:8661-8668.
17. Brennan, M. B., and G. R. Stark. 1983. Interferon pretreatment inhibits simian virus 40 infections by blocking the onset of early transcription. Cell 33:811-816.
18. Charleston, B., M. D. Fray, S. Baigent, B. V. Carr, and W. I. Morrison. 2001. Establishment of persistent infection with non-cytopathic bovine viral diarrhoea virus in cattle is associated with a failure to induce type I interferon. J. Gen. Virol. 82:1893-1897.
19. Cossarizza, A., C. Franceschi, D. Monti, S. Salvioli, E. Bellesia, R. Rivabene, L. Biondo, G. Rainaldi, A. Tinari, and W. Malorni. 1995. Protective effect of N-acetylcysteine in tumor necrosis factor-α-induced apoptosis in U937 cells: the role of mitochondria. Exp. Cell Res. 220:232-240.
20. Daher, K. A., and C. E. Samuel. 1982. Mechanism of interferon action. Differential effect of interferon on the synthesis of simian virus 40 and reovirus polypeptides in monkey kidney cells. Virology 117:379-390.
21. Deng, R., and K. V. Brock. 1992. Molecular cloning and nucleotide sequence of a pestivirus genome, noncytopathic bovine viral diarrhea virus strain SD-1. Virology 191:867-869.
22. Der, S. D., A. M. Zhou, B. R. G. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:15623-15628.
23. Diamond, M. S., T. G. Roberts, D. Edgil, B. Lu, J. Ernst, and E. Harris. 2000. Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J. Virol. 74:4957-4966.
24. Diderholm, H., and Z. Dinter. 1966. Interference between strains of bovine virus diarrhea virus and their capacity to suppress interferon of a heterologous virus. Proc. Soc. Exp. Biol. Med. 121:976-980.
25. Durantel, D., S. Carrouée-Durantel, N. Branza-Nichita, R. A. Dwek, and N. Zitzmann. 2004. Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus. Antimicrob. Agents Chemother. 48:497-504.
26. El-Hage, N., and G. X. Luo. 2003. Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA. J. Gen. Virol. 84:2761-2769.
27. Flohr, F., S. Schneider-Schaulies, O. Haller, and G. Kochs. 1999. The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett. 463:24-28.
28. François, C., G. Duverlie, D. Rebouillat, H. Khorsi, S. Castelain, H. E. Blum, A. Gatignol, C. Wychowski, D. Moradpour, and E. F. Meurs. 2000. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J. Virol. 74:5587-5596.
29. García-Sastre, A. 2002. Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. Microbes Infect. 4:647-655.
30. Gillespie, J. H., D. S. Robson, F. W. Scott, and E. I. Schiff. 1985. In vitro protective effect of bacteria-derived bovine alpha interferon I1 against selected bovine viruses. J. Clin. Microbiol. 22:912-914.
31. Givens, M. D., A. M. Heath, K. V. Brock, B. W. Brodersen, R. L. Carson, and D. A. Stringfellow, 2003. Detection of bovine viral diarrhea virus in semen obtained after inoculation of seronegative postpubertal bulls. Am. J. Vet. Res. 64:428-434.
32. Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. J. Gen. Virol. 81:2341-2364.
33. Haller, O., and G. Kochs. 2002. Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3:710-717.
34. Hengel, H., U. H. Koszinowski, and K. K. Conzelmann. 2005. Viruses know it all: new insights into IFN networks. Trends Immunol. 26:396-401.
35. Horisberger, M. A., and M. C. Gunst. 1991. Interferon-induced proteins: identification of Mx proteins in various mammalian species. Virology 180: 185-190.
36. Houe, H. 2003. Economic impact of BVDV infection in dairies. Biologicals 31:137-143.
37. Hu, Y., and T. W. Conway. 1993. 2-Aminopurine inhibits the double-stranded RNA-dependent protein kinase both in vitro and in vivo. J. Interferon Res. 13:323-328.
38. Huang, S., L. K. Qu, A. R. Cuddihy, R. Ragheb, Y. Taya, and A. E. Koromilas. 2003. Protein kinase inhibitor 2-aminopurine overrides multiple genotoxic stress-induced cellular pathways to promote cell survival. Oncogene 22:3721-3733.
39. Jones, M., A. Davidson, L. Hibbert, P. Gruenwald, J. Schlaak, S. Ball, G. R. Foster, and M. Jacobs. 2005. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J. Virol. 79:5414-5420.
40. Jungi, T. W., H. Pfister, H. Sager, R. Fatzer, M. Vandevelde, and A. Zurbriggen. 1997. Comparison of inducible nitric oxide synthase expression in the brains of Listeria monocytogenes-infecled cattle, sheep, and goats and in macrophages stimulated in vitro. Infect. Immun. 65:5279-5288.
41. Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675-687.
42. Lackner, T., A. Müller, A. Pankraz, P. Becher, H. J. Thiel, A. E. Gorbalenya, and N. Tautz. 2004. Temporal modulation of an autoprotease is crucial for replication and pathogenicity of an RNA virus. J. Virol. 78:10765-10775.
43. Li, X. L., J. A. Blackford, and B. A. Hassel. 1998. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. J. Virol. 72:2752-2759.
44. Liebler-Tenorio, E. M., J. F. Ridpath, and J. D. Neill. 2004. Distribution of viral antigen and tissue lesions in persistent and acute infection with the homologous strain of noncytopathic bovine viral diarrhea virus. J. Vet. Diagn. Investig. 16:388-396.
45. Martinand, C., T. Salehzada, M. Silhol, B. Lebleu, and C. Bisbal. 1998. RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)- infected cells. Eur. J. Biochem. 254:248-255.
46. Miyanari, Y., M. Hijikata, M. Yamaji, M. Hosaka, H. Takahashi, and K. Shimotohno. 2003. Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication. J. Biol. Chem. 278:50301-50308.
47. Moennig, V., and B. Liess. 1995. Pathogenesis of intrauterine infections with bovine viral diarrhea virus. Vet. Clin. N. Am. Food Anim. Pract 11:477-487.
48. Moradpour, D., R. Gosert, D. Egger, F. Penin, H. E. Blum, and K. Bienz. 2003. Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex. Antivir. Res. 60:103-109.
49. Müller-Doblies, D., M. Ackermann, and A. Metzler. 2002. In vitro and in vivo detection of Mx gene products in bovine cells following stimulation with alpha/beta interferon and viruses. Clin. Diagn. Lab. Immunol. 9:1192-1199.
50. Munoz-Jordán, J. L., M. Laurent-Rolle, J. Ashour, L. Martínez-Sobrido, M. Ashok, W. I. Lipkin, and A. García-Sastre. 2005. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79:8004-8013.
51. Munoz-Jordán, J. L., G. G. Sanchez-Burgos, M. Laurent-Rolle, and A. García-Sastre. 2003. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA 100:14333-14338.
52. Naka, K., K. Takemoto, K. Abe, H. Dansako, M. Ikeda, K. Shimotohno, and N. Kato. 2005. Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptors. J. Gen. Virol. 86:2787-2792.
53. Ouzounov, S., A. Mehta, R. A. Dwek, T. M. Block, and R. Jordan. 2002. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Antivir. Res. 55:425-435.
54. Peek, S. F., M. D. Bonds, D. G. Gangemi, C. B. Thomas, and R. D. Schultz. 2004. Evaluation of cytotoxicity and antiviral activity of recombinant human interferon alfa-2a and recombinant human interferon alfa-B/D hybrid against bovine viral diarrhea virus, infectious bovine rhinotracheitis virus, and vesicular stomatitis virus in vitro. Am. J. Vet. Res. 65:871-874.
55. Peek, S. F., M. D. Bonds, P. Schaele, S. Weber, K. Friedrichs, and R. D. Schultz. 2004. Evaluation of antiviral activity and toxicity of recombinant human interferon alfa-2a in calves persistently infected with type 1 bovine viral diarrhea virus. Am. J. Vet. Res. 65:865-870.
56. Pellerin, C., J. Van den Hurk, J. Lecomte, and P. Tijssen. 1994. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology 203:260-268.
57. Perler, L., H. Pfister, M. Schweizer, E. Peterhans, and T. W. Jungi. 1999. A bioassay for interferon type I based on inhibition of Sendai virus growth. J. Immunol. Methods 222:189-196.
58. Perler, L., M. Schweizer, T. W. Jungi, and E. Peterhans. 2000. Bovine viral diarrhoea virus and bovine herpesvirus-1 prime uninfected macrophages for lipopolysaccharide-triggered apoptosis by interferon-dependent and -independent pathways. J. Gen. Virol. 81:881-887.
59. Ploegh, H. L. 1998. Viral strategies of immune evasion. Science 280:248-253.
60. Qvist, P., B. Aasted, B. Bloch, A. Meyling, L. Ronsholt, and H. Houe. 1990. Flow cytometric detection of bovine viral diarrhea virus in peripheral blood leukocytes of persistently infected cattle. Can. J. Vet. Res. 54:469-472.
61. Reed, L. J., and H. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
62. Ridpath, J. F., T. L. Lewis, S. R. Bolin, and E. S. Berry. 1991. Antigenic and genomic comparison between non-cytopathic and cytopathic bovine viral diarrhoea viruses isolated from cattle that had spontaneous mucosal disease. J. Gen. Virol. 72:725-729.
63. Rossi, C. R., G. K. Kiesel, and E. J. Hoff. 1980. Factors affecting the assay of bovine type I interferon on bovine embryonic lung cells. Am. J. Vet. Res. 41:552-556.
64. Rüfenacht, J., P. Schaller, L. Audigé, M. Strasser, and E. Peterhans. 2000. Prevalence of cattle infected with bovine viral diarrhoea virus in Switzerland. Vet. Rec. 147:413-417.
65. pro. J. Virol. 77:7645-7654.
66. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
67. Schlender, J., B. Bossert, U. Buchholz, and K. K. Conzelmann. 2000. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 74: 8234-8242.
68. Schweizer, M., and E. Peterhans. 1999. Oxidative stress in cells infected with bovine viral diarrhoea virus: a crucial step in the induction of apoptosis. J. Gen. Virol. 80:1147-1155.
69. Schweizer, M., and E. Peterhans. 2001. Noncytopathic bovine viral diarrhea virus inhibits double-stranded RNA-induced apoptosis and interferon synthesis. J. Virol. 75:4692-4698.
70. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
71. Sentsui, H., R. Takami, T. Nishimori, K. Murakami, T. Yokoyama, and Y. Yokomizo. 1998. Anti-viral effect of interferon-alpha on bovine viral diarrhea virus. J. Vet. Med. Sci. 60:1329-1333.
72. Sopp, P., L. B. Hooper, M. C. Clarke, C. J. Howard, and J. Brownlie. 1994. Detection of bovine viral diarrhoea virus p80 protein in subpopulations of bovine leukocytes. J. Gen. Virol. 75:1189-1194.
73. Stojdl, D. F., N. Abraham, S. Knowles, R. Marius, A. Brasey, B. D. Lichty, E. G. Brown, N. Sonenberg, and J. C. Bell. 2000. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J. Virol. 74:9580-9585.
74. Tortorella, D., B. E. Gewurz, M. H. Furman, D. J. Schust, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18:861-926.
75. Trottier, M. D., B. M. Pallan, and C. S. Reiss. 2005. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology 333:215-225.
76. Tsuchiya, Y., A. Uchimura, H. Tajika, K. Sakamoto, T. Furuya, K. Sato, K. Nanba, and Y. Miura. 1993. Reverse interference method for measurement of hog-cholera virus (HCV) and anti-HCV antibody. J. Vet. Med. Sci. 55: 233-236.
77. Uchil, P. D., and V. Satchidanandam. 2003. Architecture of the flaviviral replication complex-protease, nuclease, and detergents reveal encasement within double-layered membrane compartments. J. Biol. Chem. 278:24388-24398.
78. Voges, H., G. W. Horner, S. Rowe, and G. J. Wellenberg. 1998. Persistent bovine pestivirus infection localized in the testes of an immuno-competent, non-viraemic bull. Vet. Microbiol. 61:165-175.
79. von Wussow, P., D. Jakschies, H.-K. Hochkeppel, C. Fibich, L. Penner, and H. Deicher. 1990. The human intracellular Mx-homologous protein is specifically induced by type I interferons. Eur. J. Immunol. 20:2015-2019.
80. Young, D. F., L. Andrejeva, A. Livingstone, S. Goodbourn, R. A. Lamb, P. L. Collins, R. M. Elliott, and R. E. Randall. 2003. Virus replication in engineered human cells that do not respond to interferons. J. Virol. 77:2174-2181.
81. Zhang, G., S. Aldridge, M. C. Clarke, and J. W. McCauley. 1996. Cell death induced by cytopathic bovine viral diarrhoea virus is mediated by apoptosis. J. Gen. Virol. 77:1677-1681.